Skip to main content

Research Repository

Advanced Search

Assessment of HMGA2 and PLAG1 rearrangements in breast adenomyoepitheliomas

Pareja, Fresia; Geyer, Felipe C.; Brown, David N.; Sebastião, Ana P. Martins; Gularte-Mérida, Rodrigo; Li, Anqi; Edelweiss, Marcia; Da Cruz Paula, Arnaud; Selenica, Pier; Wen, Hannah Y.; Jungbluth, Achim A.; Varga, Zsuzsanna; Palazzo, Juan; Rubin, Brian P.; Ellis, Ian O.; Brogi, Edi; Rakha, Emad A.; Weigelt, Britta; Reis-Filho, Jorge S.

Assessment of HMGA2 and PLAG1 rearrangements in breast adenomyoepitheliomas Thumbnail


Authors

Fresia Pareja

Felipe C. Geyer

David N. Brown

Ana P. Martins Sebastião

Rodrigo Gularte-Mérida

Anqi Li

Marcia Edelweiss

Arnaud Da Cruz Paula

Pier Selenica

Hannah Y. Wen

Achim A. Jungbluth

Zsuzsanna Varga

Juan Palazzo

Brian P. Rubin

Edi Brogi

EMAD RAKHA Emad.Rakha@nottingham.ac.uk
Professor of Breast Cancer Pathology

Britta Weigelt

Jorge S. Reis-Filho



Abstract

Breast adenomyoepitheliomas (AMEs) are rare epithelial-myoepithelial neoplasms that may occasionally produce myxochondroid matrix, akin to pleomorphic adenomas (PAs). Regardless of their anatomic location, PAs often harbor rearrangements involving HMGA2 or PLAG1. We have recently shown that the repertoire of somatic genetic alterations of AMEs varies according to their estrogen receptor (ER) status; whilst the majority of ER-positive AMEs display mutually exclusive PIK3CA or AKT1 hotspot mutations, up to 60% of ER-negative AMEs harbor concurrent HRAS Q61 hotspot mutations and mutations affecting either PIK3CA or PIK3R1. Here, we hypothesized that a subset of AMEs lacking these somatic genetic alterations could be underpinned by oncogenic fusion genes, in particular those involving HMGA2 or PLAG1. Therefore, we subjected 13 AMEs to RNA-sequencing for fusion discovery (n = 5) and/or fluorescence in situ hybridization (FISH) analysis for HMGA2 and PLAG1 rearrangements (n = 13). RNA-sequencing revealed an HMGA2-WIF1 fusion gene in an ER-positive AME lacking HRAS, PIK3CA and AKT1 somatic mutations. This fusion gene, which has been previously described in salivary gland PAs, results in a chimeric transcript composed of exons 1–5 of HMGA2 and exons 3–10 of WIF1. No additional in-frame fusion genes or HMGA2 or PLAG1 rearrangements were identified in the remaining AMEs analyzed. Our results demonstrate that a subset of AMEs lacking mutations affecting HRAS and PI3K pathway-related genes may harbor HMGA2-WIF1 fusion genes, suggesting that a subset of breast AMEs may be genetically related to PAs or that a subset of AMEs may originate in the context of a PA.

Citation

Pareja, F., Geyer, F. C., Brown, D. N., Sebastião, A. P. M., Gularte-Mérida, R., Li, A., …Reis-Filho, J. S. (2019). Assessment of HMGA2 and PLAG1 rearrangements in breast adenomyoepitheliomas. npj Breast Cancer, 5, Article 6 (2019). https://doi.org/10.1038/s41523-018-0101-7

Journal Article Type Article
Acceptance Date Nov 27, 2018
Online Publication Date Jan 18, 2019
Publication Date Jan 18, 2019
Deposit Date Aug 8, 2019
Publicly Available Date Aug 8, 2019
Journal npj Breast Cancer
Electronic ISSN 2374-4677
Publisher Nature Publishing Group
Peer Reviewed Peer Reviewed
Volume 5
Article Number 6 (2019)
DOI https://doi.org/10.1038/s41523-018-0101-7
Public URL https://nottingham-repository.worktribe.com/output/2406433
Publisher URL https://www.nature.com/articles/s41523-018-0101-7

Files




You might also like



Downloadable Citations